45
Participants
Start Date
March 18, 2022
Primary Completion Date
October 1, 2026
Study Completion Date
October 1, 2026
Biopsy Procedure
Undergo tissue biopsy
Biospecimen Collection
Undergo blood sample collection
Computed Tomography
Undergo CT
Pomalidomide
Given PO
X-Ray Imaging
Undergo x-ray imaging
Mount Sinai Hospital, New York
NYP/Weill Cornell Medical Center, New York
Montefiore Medical Center-Einstein Campus, The Bronx
University of Pennsylvania/Abramson Cancer Center, Philadelphia
Pennsylvania Hospital, Philadelphia
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Miami Cancer Institute, Miami
Ohio State University Comprehensive Cancer Center, Columbus
University of Illinois, Chicago
Washington University School of Medicine, St Louis
Thomas Street at Quentin Mease Health Center, Houston
M D Anderson Cancer Center, Houston
UC San Diego Moores Cancer Center, La Jolla
Virginia Mason Medical Center, Seattle
Boston Medical Center, Boston
National Cancer Institute (NCI)
NIH